Pinnacle Wealth Planning Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.46M Buy
13,739
+22
+0.2% +$4.73K 0.33% 49
2026
Q1
$2.98M Buy
13,717
+373
+3% +$82.7K 0.31% 46
2025
Q4
$3.05M Sell
13,344
-278
-2% -$63.3K 0.32% 42
2025
Q3
$3.15M Buy
13,622
+1,182
+10% +$241K 0.37% 38
2025
Q2
$2.31M Buy
12,440
+204
+2% +$37.9K 0.3% 44
2025
Q1
$2.56M Buy
12,236
+148
+1% +$28.8K 0.39% 39
2024
Q4
$2.15M Sell
12,088
-2,985
-20% -$549K 0.32% 43
2024
Q3
$2.98M Buy
15,073
+126
+0.8% +$23.5K 0.4% 39
2024
Q2
$2.56M Buy
14,947
+51
+0.3% +$8.45K 0.37% 42
2024
Q1
$2.71M Buy
14,896
+59
+0.4% +$10.2K 0.4% 43
2023
Q4
$2.3M Sell
14,837
-1,792
-11% -$261K 0.36% 43
2023
Q3
$2.48M Buy
16,629
+305
+2% +$44.8K 0.41% 40
2023
Q2
$2.2M Sell
16,324
-716
-4% -$105K 0.36% 44
2023
Q1
$2.72M Buy
17,040
+312
+2% +$47.7K 0.45% 40
2022
Q4
$2.7M Buy
16,728
+2,123
+15% +$326K 0.48% 41
2022
Q3
$1.96M Sell
14,605
-1,282
-8% -$184K 0.36% 46
2022
Q2
$2.43M Buy
15,887
+194
+1% +$29.6K 0.44% 38
2022
Q1
$2.54M Buy
15,693
+1,098
+8% +$159K 0.46% 38
2021
Q4
$1.98M Buy
14,595
+1,028
+8% +$121K 0.39% 51
2021
Q3
$1.46M Buy
13,567
+28
+0.2% +$3.2K 0.32% 59
2021
Q2
$1.52M Buy
13,539
+46
+0.3% +$5.18K 0.35% 56
2021
Q1
$1.46M Buy
13,493
+738
+6% +$78.9K 0.37% 54
2020
Q4
$1.37M Buy
12,755
+161
+1% +$15.5K 0.33% 50
2020
Q3
$1.1M Buy
12,594
+45
+0.4% +$4.24K 0.36% 52
2020
Q2
$1.23M Buy
12,549
+3
+0% +$264 0.4% 46
2020
Q1
$955K Buy
12,546
+140
+1% +$11.9K 0.45% 44
2019
Q4
$1.1M Buy
12,406
+6,434
+108% +$534K 0.52% 36
2019
Q3
$452K Buy
5,972
+1,602
+37% +$110K 0.25% 84
2019
Q2
$317K Buy
4,370
+464
+12% +$36.5K 0.19% 104
2019
Q1
$315K Sell
3,906
-332
-8% -$27.2K 0.21% 99
2018
Q4
$390K Sell
4,238
-416
-9% -$36.6K 0.25% 77
2018
Q3
$440K Buy
4,654
+280
+6% +$26.6K 0.4% 85
2018
Q2
$405K Sell
4,374
-126
-3% -$12.3K 0.39% 87
2018
Q1
$426K Buy
4,500
+2,468
+121% +$271K 0.44% 78
2017
Q4
$196K Buy
+2,032
New +$192K 0.4% 59

Other funds holding ABBV

Pinnacle Wealth Planning Services's ABBV Position: Q2 2026 in Review

Pinnacle Wealth Planning Services increased its AbbVie (ABBV) stake by 0.16% in Q2 2026, buying an estimated $4.73K and bringing the position to 13,739 shares worth $3.46M. The position accounts for 0.33% of the portfolio, ranked #49.

Pinnacle Wealth Planning Services first reported a position in ABBV in Q4 2017 and has held it in 35 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Pinnacle Wealth Planning Services held 13,739 shares of AbbVie worth $3.46M as of Q2 2026.
  • Pinnacle Wealth Planning Services bought 22 AbbVie shares in Q2 2026, an estimated $4.73K.
  • AbbVie made up 0.33% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #49 holding.
  • Pinnacle Wealth Planning Services first reported a position in AbbVie in Q4 2017 and has held it in 35 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.